GNCAQ — Genocea Biosciences Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual balance sheet for Genocea Biosciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2017 December 31st	2018 December 31st	2019 December 31st	2020 December 31st	2021 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	12.3	26.4	40.1	79.8	37.1
Prepaid Expenses
Total Current Assets	13.1	27.1	41.6	82.2	41.8
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	3.46	2.58	8.92	14.4	13.3
Other Long Term Assets
Total Assets	17.5	31.1	52.6	98.5	56
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	15.8	10.7	6.28	25	18.7
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	23.5	23.8	27.6	89.5	28.9
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	-6.05	7.33	25	8.98	27.1
Total Liabilities & Shareholders' Equity	17.5	31.1	52.6	98.5	56
Total Common Shares Outstanding
Total Preferred Shares Outstanding